ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 296

Knee Osteoarthritis As Risk for Hip Osteoarthritis

Chan Kim1, Shanshan Sheehy2, Cara Lewis3, Mary M Clancy4,5,6, Michael C. Nevitt7, James Torner8, Cora E. Lewis9, Ali Guermazi10 and David T. Felson11, 1Rheumatology and Clinical Epidemiology, Boston University School of Medicine, Boston, MA, 2Clinical Epidemiology Research & Training Unit, Boston University, Boston, MA, 3Physical Therapy and Athletic Training, Boston University, Boston, MA, 4Clinical Epidemiology, BUSM, Boston, MA, 5Clinical Epidemiology, Boston University School Medical, Boston, MA, 6Clinical Epidemiology, Boston University Sch Med, Boston, MA, 7Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 8University of Iowa, UIowa, Iowa City, IA, 9University of Alabama Birmingham, Birmingham, AL, 10Boston University School of Medicine, Boston, MA, 11Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Hip, Knee and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoarthritis – Clinical Aspects - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Knee osteoarthritis as risk factor for hip osteoarthritis

Background/Purpose: While the hip and knee are linked biomechanically, the risk of hip osteoarthritis (OA) in persons with knee OA has not been well studied.  Knee OA is associated with weak hip girdle muscles which may predispose to hip OA. Furthermore, persons with painful knee OA may alter their gait and abnormally load other lower extremity joints.  We examined the risk of hip OA in those with knee OA in the Multicenter Osteoarthritis Study (MOST).  

Methods: MOST is a NIH funded cohort study of risk factors for knee OA.  To evaluate hip OA, we used long limb films which included hip imaging obtained at baseline and 60 months follow-up.  Radiographic hip OA was defined using the modified Croft definition, and we defined incident radiographic hip OA as development of OA at 60 months.  To evaluate knee OA, PA and lateral weight bearing films were obtained at baseline.  A knee had radiographic OA if that knee had either tibio-femoral or patello-femoral OA (Kellgren and Lawrence score >=2).  Symptomatic knee OA was defined as knee with radiographic OA and knee pain on most days in a month.  For the 1st analysis, the exposure groups were knees with or without (either unilateral or bilateral) radiographic knee OA at baseline.  For the 2nd analysis, the exposure groups were knees with or without symptomatic knee OA at baseline.  The outcomes for both analyses were incident radiographic hip OA.  For both analyses, we compared the risk of incident radiographic hip OA in hips with or without (radiographic or symptomatic) knee OA.  The analyses were adjusted for hip OA risk factors including age, sex, BMI, knee injury/surgery.  We carried out subanalyses among those with unilateral prevalent radiographic and symptomatic knee OA to compare the risk of incident ipsilateral vs contralateral hip OA at 60 months.

Results: In the 1st analysis, the risk of incident radiographic hip OA with any radiographic knee OA was not significantly greater than risk of incident radiographic hip OA without any radiographic knee OA (see table 1).  For the 2nd analysis, there was an increased risk of incident radiographic hip OA with any symptomatic knee OA (see table 1), and this increased risk was limited to the subset of subjects with unilateral symptomatic knee OA (adjusted OR 1.99, p = 0.01).  Among those with prevalent radiographic or symptomatic knee OA, we found no predilection for ipsilateral vs. contralateral incident hip OA (see table 2).

Conclusion: Pre-existing radiographic knee OA did not increase risk for incident radiographic hip OA, but symptomatic knee OA may increase risk for incident radiographic hip OA.   


Disclosure: C. Kim, None; S. Sheehy, None; C. Lewis, None; M. M. Clancy, None; M. C. Nevitt, None; J. Torner, None; C. E. Lewis, None; A. Guermazi, MerckSerono, TissueGene, OrthoTrophix, AstraZeneca, Genzyme, 5,Boston Imaging Core Lab, LLC, 1; D. T. Felson, zimmer knee creations, 5.

To cite this abstract in AMA style:

Kim C, Sheehy S, Lewis C, Clancy MM, Nevitt MC, Torner J, Lewis CE, Guermazi A, Felson DT. Knee Osteoarthritis As Risk for Hip Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/knee-osteoarthritis-as-risk-for-hip-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knee-osteoarthritis-as-risk-for-hip-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology